Page last updated: 2024-09-03

wy 50324 and Brain Ischemia

wy 50324 has been researched along with Brain Ischemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dawson, LA; Djali, S; Galandak, J	1

Other Studies

1 other study(ies) available for wy 50324 and Brain Ischemia

Article	Year
Attenuation of ischemic efflux of endogenous amino acids by the novel 5-HT(1A)/5-HT(2) receptor ligand adatanserin. Neurochemistry international, 2002, Volume: 40, Issue:3 Topics: Amino Acids; Animals; Brain Ischemia; Fluorobenzenes; Hippocampus; In Vitro Techniques; Indoles; Ligands; Male; Piperazines; Piperidines; Pyridines; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2B; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Antagonists; Serotonin Receptor Agonists	2002

Article

Year

Attenuation of ischemic efflux of endogenous amino acids by the novel 5-HT(1A)/5-HT(2) receptor ligand adatanserin.

Neurochemistry international, 2002, Volume: 40, Issue:3

Topics: Amino Acids; Animals; Brain Ischemia; Fluorobenzenes; Hippocampus; In Vitro Techniques; Indoles; Ligands; Male; Piperazines; Piperidines; Pyridines; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2B; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Antagonists; Serotonin Receptor Agonists

2002